Össur hf: Interim Report Q4 2023
Announcement no. 3/2024 Interim report Q4 2023 30 January 2024 Sveinn Sölvason, President and CEO, Comments: “I’m very pleased to end the year on a solid quarter with organic growth of 9%, driven by continued strong performance in Prosthetics and Patient Care. Organic growth for the full year was 9% and in 2023 we have grown the business in all regions and business segments. We reached a major milestone in our journey to become an increasingly patient focused company, addressing chronic mobility challenges in a broader context, by acquiring FIOR & GENTZ in January 2024. With the